chr1-201648717-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM2BP4_StrongBS2
The NM_001389617.1(NAV1):āc.910A>Gā(p.Ser304Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000394 in 1,267,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001389617.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAV1 | NM_001389617.1 | c.910A>G | p.Ser304Gly | missense_variant | 5/34 | ENST00000685211.1 | NP_001376546.1 | |
NAV1 | NM_001389616.1 | c.910A>G | p.Ser304Gly | missense_variant | 4/32 | NP_001376545.1 | ||
NAV1 | NM_001389615.1 | c.910A>G | p.Ser304Gly | missense_variant | 5/31 | NP_001376544.1 | ||
NAV1 | NM_020443.5 | c.49A>G | p.Ser17Gly | missense_variant | 1/30 | NP_065176.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAV1 | ENST00000685211.1 | c.910A>G | p.Ser304Gly | missense_variant | 5/34 | NM_001389617.1 | ENSP00000510803 | P2 | ||
NAV1 | ENST00000367296.8 | c.49A>G | p.Ser17Gly | missense_variant | 1/30 | 5 | ENSP00000356265 | A2 | ||
NAV1 | ENST00000367302.5 | c.88A>G | p.Ser30Gly | missense_variant | 3/30 | 5 | ENSP00000356271 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000394 AC: 5AN: 1267758Hom.: 0 Cov.: 53 AF XY: 0.00 AC XY: 0AN XY: 622344
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.49A>G (p.S17G) alteration is located in exon 1 (coding exon 1) of the NAV1 gene. This alteration results from a A to G substitution at nucleotide position 49, causing the serine (S) at amino acid position 17 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.